Loading...
Asenapine in bipolar I disorder: evidence and place in patient management
Asenapine is a new second-generation antipsychotic approved in September 2010 by the European Medicines Agency for the treatment of bipolar disorder. It demonstrated significant efficacy compared with placebo in acute mania or mixed episodes as monotherapy or adjunctive therapy to mood stabilizers (...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3539266/ https://ncbi.nlm.nih.gov/pubmed/23342243 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622312468933 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|